发明名称 |
COMBINATION THERAPY FOR TREATMENT OF OBESITY AND DIABETES AND CONDITION RELATED THERETO AND FOR TREATMENT OF CONDITION AMELIORATED BY INCREASING BLOOD GLP-1 LEVEL |
摘要 |
<p>PROBLEM TO BE SOLVED: To provide a composition for treating or preventing diabetes or a condition related thereto comprising a therapeutically effective amount of a BRS-3 agonist and a DPP-IV inhibitor.SOLUTION: The invention relates to a combination of a certain amount of a BRS-3 agonist with a certain amount of a dipeptidyl peptidase IV (DPP-IV) inhibitor such that the combination provides an effect in lowering a blood glucose level or in increasing a blood GLP-1 level in a subject over that provided by the certain amount of the BRS-3 agonist alone or by the certain amount of the DPP-IV inhibitor alone, and to the use of such a combination for treating or preventing obesity and diabetes and conditions related thereto and conditions ameliorated by increasing a blood GLP-1 level. The invention also relates to the use of a G protein-coupled receptor to shield for GLP-1 secretagogues.</p> |
申请公布号 |
JP2015120749(A) |
申请公布日期 |
2015.07.02 |
申请号 |
JP20150057165 |
申请日期 |
2015.03.20 |
申请人 |
ARENA PHARMACEUTICALS INC |
发明人 |
CHU ZHI-LIANG;LEONARD JAMES N |
分类号 |
A61K45/06;A61P3/04;A61P3/06;A61P3/10;A61P9/00;A61P9/10;A61P9/12;A61P25/02;A61P25/08;A61P25/14;A61P25/16;A61P25/28;A61P27/02;A61P27/12;A61P43/00;C12N15/09;C12Q1/02;G01N33/15;G01N33/50 |
主分类号 |
A61K45/06 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|